May 25, 2011 | Filed under: Health,News | Posted by:
The newly approved prostate cancer pill Zytiga (abiraterone acetate) may extend life by up to four months among men with spreading cancer who have already been treated with chemotherapy, a study shows.
Posted by
on May 25, 2011. Filed under Health, News.
You can follow any responses to this entry through the RSS 2.0.
You can skip to the end and leave a response. Pinging is currently not allowed.
Posted by
on May 25, 2011. Filed under